Bioline Rx

BLRX

TEL AVIV STOCK EXCHANGEHealth Care

Income Statement

Total Revenue$28.94M

Gross Profit$19.68M

Operating Income$-20.41M

EBITDA$3.96M

EBIT$-102K

Pre-tax Income$-2.02M

Net Income$-9.22M

Cash Equivalent$29.24M

Total Debt$21.81M

Book Value$12.25M

Book Value Per Share0.01

Return on Equity (ROE)-68.50%

Return on Assets (ROA)-23.70%

Return on Invested Capital (ROI)-32.35%

Net Profit Margin-31.86%

Current Ratio1.76

Quick Ratio1.53

Long-Term Debt / Equity0.67